Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07179055 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye

Name: An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye — clinical trial record (NCT07179055)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorVanda Pharmaceuticals

Started2025-10

View on ClinicalTrials.gov ↗

Record status

This record was last updated September 17, 2025 (before its estimated September 2026 completion). Its status may not reflect the trial's current state.

Vanda Pharmaceuticals

23 trials monitored

See 3 trials at risk

The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.

Trial Details

NCT Number	NCT07179055
Lead Sponsor	Vanda Pharmaceuticals
Conditions	Dry Eye
Enrollment	160 participants
Start Date	2025-10
Primary Completion	2026-09 (estimated)
Study Completion	2026-09 (estimated)
Updated on ClinicalTrials.gov	2025-09-17